Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 6/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | BLM | P54132 | 4/20 | 1.00 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | THPO | P40225 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.63 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.63 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.63 |
| ▸ | TSHR | P16473 | 4/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxedrine SCHEMBL17726874 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1BLMTAAR1 | |
| Oxedrine SCHEMBL28287981 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1BLMTAAR1 | |
| Oxedrine SCHEMBL2283013 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1BLMTAAR1 | |
| Oxedrine SCHEMBL1487703 | 0.98 | KDM4E (0.96) | KDM4EHIF1ATDP1BLMTAAR1 | |
| SCHEMBL28858225 | 0.94 | HIF1A (0.89) | KDM4EHIF1ATDP1BLMTAAR1 | |
| SCHEMBL28193633 | 0.94 | HIF1A (0.89) | KDM4EHIF1ATDP1BLMTAAR1 | |
| Oxedrine SCHEMBL28002395 | 0.91 | HIF1A (0.82) | KDM4EHIF1ATDP1BLMTAAR1 | |
| Oxedrine SCHEMBL30559825 | 0.88 | KDM4E (0.77) | KDM4EHIF1ATDP1BLMTAAR1 | |
| Oxedrine SCHEMBL146499 | 0.88 | KDM4E (0.77) | KDM4EHIF1ATDP1BLMTAAR1 | |
| Halostachine SCHEMBL28853304 | 0.86 | HIF1A (0.75) | KDM4EHIF1ATDP1BLMTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6260 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106796-A1 | SYSTEM AND METHOD FOR THE TREATMENT OF TELOGEN EFFLUVIUM, ANDROGENETIC ALOPECIA, AND OTHER HAIR LOSS DISORDERS | FOLLEA INTERNATIONAL (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122056926-A | Probiotic composition containing melatonin and application of composition in sleep | 南京北极光生物科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122005672-A | Preparation method of Chaishao oral liquid | 徐州天意药业股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4704839-A2 | IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF | ALPHERABIO LLC (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260041652-A1 | SYSTEM AND METHOD FOR PREVENTING ALOPECIA | FOLLEA INT (US) | 2026-02-12 | — | — | US | claimed |
| US-12533327-B2 | Hexylamine salts and methods of using hexylamine | THERMOLIFE INTERNATIONAL, LLC (US) | 2026-01-27 | — | — | US | claimed |
| US-20250367206-A1 | 1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF | Ingenious Ingredients, LP (US) | 2025-12-04 | — | — | US | claimed |
| EP-4647070-A2 | A PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF | Caliway Biopharmaceuticals Co. Ltd. (TW) | 2025-11-12 | — | — | EP | claimed |
| EP-4622629-A1 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | Caliway Biopharmaceuticals Co. Ltd. (TW) | 2025-10-01 | — | — | EP | claimed |
| EP-0547065-A4 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | — | 1993-09-15 | — | — | EP | claimed |
| EP-0547065-A1 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | Biosource Technologies, Inc. (US) | 1993-06-23 | — | — | EP | claimed |
| US-5215751-A | THERAPEUTIC SYSTEM FOR THE RETARDED AND CONTROLLED TRANSDERMAL OR TRANSMUCOUS ADMINISTRATION OF ACTIVE SUBSTANCES (I) | LTS LOHMANN THERAPIE SYSTEME GMBH & CO. (DE) | 1993-06-01 | — | — | US | claimed |
| EP-0384267-B1 | THERAPEUTIC SYSTEM FOR THE SUSTAINED AND CONTROLLED TRANSDERMAL OR TRANSMUCOSAL DELIVERY OF ACTIVE AGENTS | LTS Lohmann Therapie-Systeme GmbH & Co. KG (DE) | 1993-05-26 | — | — | EP | claimed |
| WO-1992000373-A1 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | BIOSOURCE GENETICS CORPORATION (CA) | 1992-01-09 | — | — | WO | claimed |
| US-4722941-A | SALT FORMATION WITH FATTY ACIDS. ANTIBIOTICS, TRANQUILIZERS, ANAESTHETICS, VASODILATORS | KALI-CHEMIE PHARMA GMBH (DE) | 1988-02-02 | — | — | US | claimed |
| US-4591551-A | ENZYMATIC TRANSMETHYLATION | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1986-05-27 | — | — | US | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4108973-A | OXIDATION | HOFFMANN-LA ROCHE INC. (US) | 1978-08-22 | — | — | US | claimed |